Investors Information
 
 
  
 
Established on September 2000, the group is composed of GalMed Holding Inc. (a British Virgin Islands company), holding 100% of GalMed International Ltd. (a European Maltese entity), the IP holder, which holds 100% of GalMed Medical Research Ltd (an Israeli company), the group’s R&D arm.
GalMed activities were initially funded by its founding members, among which are seasoned Israeli & international investors such as the Peleg family, Brack Capital Investments, UniPharm Ltd., Nams Europe and G. Yarom Medical Research Ltd. To date, GalMed sucessefuly completed three financing rounds. 
 
For further information, please contact:

Allen Baharaff
 

  

Back to Top